Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of ...

Mankind Pharma, controlled by billionaire brothers Ramesh and Rajeev Juneja, announced in July plans to buy Mumbai-based ...

Lawmakers accused EPSS of illicitly selling medicines and pharmaceutical supplies imported using public funds to private ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

Aptar Pharma, a provider of drug delivery systems, has acquired all device technology assets from SipNose Nasal Delivery ...

Chennai police have successfully apprehended two suspects involved in the kidnapping of a pharmaceutical staff member due to ...

BALLERUP, Denmark-- ( BUSINESS WIRE )--LEO Pharma today announced its commitment to achieving a net-zero climate target by ...